Intellia Therapeutics Inc (NASDAQ:NTLA)

113.48
Delayed Data
As of Nov 26
 -2.04 / -1.77%
Today’s Change
35.61
Today|||52-Week Range
202.73
+108.60%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Operating ActivitiesNet Income / Starting Line-12.4M-31.6M-67.5M-85.3M
 
 
 
 
 
Depreciation328.0K1.1M3.0M4.5M
 
 
 
 
 
Total Other Cash Flow305.0K6.7M15.5M16.4M
 
 
 
 
 
Funds From Operations-11.8M-23.8M-49.1M-64.4M
 
 
 
 
 
Funds From/For Other Operating Expenses-10.0M-59.9M16.2M-3.2M
 
 
 
 
 
Net Cash Flow - Operating Activities-1.8M36.1M-65.3M-61.3M
 
 
 
 
 
 
InvestingIncrease In Investments0.00--0.00-254.6M
 
 
Capital Expenditures-2.6M-6.2M-10.1M-6.4M
 
 
 
 
 
Fixed Asset Disposal------131.0K
 
 
Net Cash Flow Investing-2.6M-6.2M-10.1M-260.8M
 
 
 
 
 
 
FinancingShort Term Borrowings0.000.000.000.00--
Long Term Borrowings0.000.000.000.00--
Long Term Debt Reduction0.000.000.000.00--
Net Proceeds Stock Sale74.1M167.9M143.0M40.2M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing3.8M600.0K0.000.00
 
 
 
Net Cash Flow - Financing70.3M167.3M143.0M40.2M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash----------
 
Net Change In Cash66.0M197.2M67.6M-281.8M